GlassScriptPhysician profile
Faisal Masood
NPI 1245737261
$5,017.25
in general payments reported to CMS, 2019-2025
12 companies · $2,943 in 2025
The $2,943 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $18.65 · 2022: $342 · 2023: $488 · 2024: $1,107 · 2025: $2,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Travel and Lodging: $738 · Gift: $249 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.08 |
| Travel and Lodging | $738.28 |
| Gift | $249.43 |
| Education | $182.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,012.99 | 2019-2025 | General - Therapies, Rotablator Rotational Atherectomy System Console Kit, Opticross |
| Medtronic, INC. | $589.82 | 2025 | Onyx Frontier, Resolute Onyx |
| Edwards Lifesciences Corporation | $483.75 | 2024-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $372.83 | 2024-2025 | Impella |
| Zoll Circulation INC | $362.50 | 2024 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Angiodynamics, INC. | $296.94 | 2024-2025 | Alphavac |
| Abbott Laboratories | $288.83 | 2019-2022 | |
| Surmodics, INC. | $271.85 | 2023-2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath |
| Janssen Pharmaceuticals, INC | $217.64 | 2022-2023 | Xarelto |
| Veryan Medical Incorporated | $68.61 | 2023 | Biomimics 3d Vascular Stent System |
| Philips North America LLC | $32.84 | 2024 | (Ao0) Igt Devices Intracardiac |
| Abbvie INC. | $18.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Masood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.